Company profile
Welcome To Blue Earth Diagnostics | A Bracco Company
Established molecular imaging company on a growth trajectory to provide innovative diagnostics solutions, driving future therapies in cancer.
Updated 06 Jun 2026 16:52
Financial period: 1 Jan 2024 to 31 Dec 2024
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
TM01 | Transaction MzQ0NDc0NDY0N2FkaXF6a2N4
Published 25 Nov 2024 10:06
CS01 | Transaction MzQ0NDc4MzI3MWFkaXF6a2N4
Published 25 Nov 2024 02:26
CH01 | Transaction MzQ0NDc4MjU4MGFkaXF6a2N4
Published 25 Nov 2024 02:22
CH01 | Transaction MzQ0NDc4MTM0NGFkaXF6a2N4
Published 25 Nov 2024 02:19
TM02 | Transaction MzQ0MjAyMTM1OWFkaXF6a2N4
Published 05 Nov 2024 10:39
AP03 | Transaction MzQ0MjAyMTM1OGFkaXF6a2N4
Published 05 Nov 2024 10:39
Company registered at Companies House
1 Apr 2015 to 31 Mar 2018
In the case of prostate cancer there is a need for better diagnostic imaging methods. Current methods are neither sensitive nor specific enough to positively direct prostate cancer patient management. Increased cellular metabolism and an associated increase in amino acid transport is a requirement for the growth and proliferation of malignant tumours. The...
